Glen MacDonald
2019
In 2019, Glen MacDonald earned a total compensation of $582.8K as Chief Technology Officer at Eleven Biotherapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $133,100 |
|---|---|
| Option Awards | $142,061 |
| Salary | $297,382 |
| Other | $10,247 |
| Total | $582,790 |
MacDonald received $297.4K in salary, accounting for 51% of the total pay in 2019.
MacDonald also received $133.1K in non-equity incentive plan, $142.1K in option awards and $10.2K in other compensation.
Rankings
In 2019, Glen MacDonald's compensation ranked 11,296th out of 13,971 executives tracked by ExecPay. In other words, MacDonald earned more than 19.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,296 out of 13,971 | 19th |
Division Manufacturing | 4,573 out of 5,701 | 20th |
Major group Chemicals And Allied Products | 1,799 out of 2,200 | 18th |
Industry group Drugs | 1,547 out of 1,886 | 18th |
Industry Pharmaceutical Preparations | 1,146 out of 1,398 | 18th |
Source: SEC filing on March 25, 2021.
MacDonald's colleagues
We found three more compensation records of executives who worked with Glen MacDonald at Eleven Biotherapeutics in 2019.